Barth R F, O'Hara J J, Duquesnoy R J, Chen S N, Winklehake J L
Immunology. 1982 Nov;47(3):511-23.
The present study was designed to investigate alterations in the blastogenic response of dinitrophenyl (DNP)-modified normal human lymphocytes. Cells were isolated from heparinized blood and treated with dinitrofluorobenzene (DNFB) at ratios ranging from 10 to 10 molecules per cell. Unmodified and DNP-modified lymphocytes were cultured in the presence of Concanavalin A, pokeweed mitogen or phytohaemagglutinin (PHA). Mixed lymphocyte cultures (MLC) were set up using unmodified and DNP-modified lymphocytes as both stimulators and responders. DNP-modified cells had normal blastogenic responses to all three lectins when treated with amounts of DNFB <10 molecules/cell, but were totally unresponsive when treated with >3 × 10 molecules. Cells treated with 10–4 × 10 molecules of DNFB had no reduction in viability as determined by trypan blue exclusion, but at ratios >10 molecules, incorporation of H-labelled amino acids, H-uridine and H-thymidine was decreased. MLC reactivity showed similar impairment with stimulator activity dropping off following treatment with 10 and responder activity with 10 molecules/cell. I-labelled antibody directed against DNP was bound to modified cells suggesting that DNP groups may have been expressed on the cell surface. Concomitantly, there were changes in the expression of HLA antigens on DNP-modified cells, as shown by the detection of new antigens or an increase in reactivity of cells expressing previously identified antigens. Other studies, carried out in parallel with the present one, suggest that these alterations may be due to configurational and/or conformational changes in membrane proteins that are essential for mitogen responsiveness and MLC activity and also may define HLA specificities. The major point that emerges from the present study is that DNP, and inferentially TNP derivitization of lymphocytes, may not only bring about the expression of new antigenic determinants, but also may affect the intrinsic ability of lymphocytes to respond to an antigenic or a mitogenic stimulus.
本研究旨在调查二硝基苯基(DNP)修饰的正常人淋巴细胞的增殖反应变化。细胞从肝素化血液中分离出来,并用二硝基氟苯(DNFB)以每细胞10至10个分子的比例进行处理。未修饰和DNP修饰的淋巴细胞在伴刀豆球蛋白A、商陆有丝分裂原或植物血凝素(PHA)存在的情况下进行培养。使用未修饰和DNP修饰的淋巴细胞作为刺激细胞和反应细胞建立混合淋巴细胞培养(MLC)。当用<10个分子/细胞的DNFB处理时,DNP修饰的细胞对所有三种凝集素均有正常的增殖反应,但当用>3×10个分子处理时则完全无反应。用10 - 4×10个分子的DNFB处理的细胞,经台盼蓝排斥法测定其活力无降低,但当比例>10个分子时,H标记的氨基酸、H-尿苷和H-胸苷的掺入减少。MLC反应性显示出类似的损伤,在用10个分子处理后刺激细胞活性下降,用10个分子/细胞处理后反应细胞活性下降。针对DNP的I标记抗体与修饰细胞结合,表明DNP基团可能已在细胞表面表达。同时,DNP修饰细胞上HLA抗原的表达发生了变化,表现为检测到新抗原或表达先前鉴定抗原的细胞反应性增加。与本研究同时进行的其他研究表明,这些改变可能是由于膜蛋白的构型和/或构象变化所致,这些变化对于有丝分裂原反应性和MLC活性至关重要,并且还可能确定HLA特异性。本研究得出的主要观点是,DNP以及由此推断的淋巴细胞的TNP衍生化,不仅可能导致新抗原决定簇的表达,还可能影响淋巴细胞对抗抗原或有丝分裂原刺激的内在能力。